Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Hepatology (Baltimore, Md.)|February 21, 2022
Changes in serum hepatitis B surface and e antigen, interferon-inducible protein 10, and aminotransferase levels during combination therapy of immune-tolerant chronic hepatitis BRobert Perrillo, Hsing-Hua S Lin, Kathleen B Schwarz, et al.
Antiviral Therapy|April 27, 2016
Clinical utility of HCV core antigen detection and quantification in the diagnosis and management of patients with chronic hepatitis C receiving an all-oral, interferon-free regimenStéphane Chevaliez, Jordan Feld, Kevin Cheng, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 2, 2024
Estimating the prevalence of hepatitis delta virus infection among adults in the United States: A meta-analysisRobert J Wong, Carol Brosgart, Steven S Wong, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|January 15, 2024
National Hepatitis C estimates: Incidence, prevalence, undiagnosed proportion and treatment, Canada, 2019Nashira Popovic, Anson Williams, Simone Périnet, et al.
Journal of Managed Care & Specialty Pharmacy|May 29, 2019
Direct-Acting Antivirals for Hepatitis C: Predictors of Early Discontinuation in the Real WorldMarina Amaral de Ávila Machado, Cristiano Soares de Moura, Marina Klein, et al.
Journal of Viral Hepatitis|March 19, 2020
The impact of SVR from direct-acting antiviral- and interferon-based treatments for HCV on hepatocellular carcinoma riskNaveed Z Janjua, Stanley Wong, Maryam Darvishian, et al.
Annals of Hepatology|August 16, 2017
Wait Time for Curative Intent Radio Frequency Ablation is Associated with Increased Mortality in Patients with Early Stage Hepatocellular CarcinomaMayur Brahmania, Osman Ahmed, Melissa Kelley, et al.
Journal of Viral Hepatitis|August 13, 2024
Mixed-Genotype HCV Direct Acting Antiviral Outcomes: A CANUHC AnalysisHaris Imsirovic, Gisela Macphail, Brian Conway, et al.
Journal of Viral Hepatitis|April 15, 2024
An updated assessment of hepatitis delta prevalence among adults in Canada: A meta-analysisRobert J Wong, Grishma Hirode, Jordan Feld, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 17, 2016
Sofosbuvir and Velpatasvir Combination Improves Patient-reported Outcomes for Patients With HCV Infection, Without or With Compensated or Decompensated CirrhosisZobair M Younossi, Maria Stepanova, Jordan Feld, et al.
Pageof 4